Search
for

    GlossaryDopamine Agonists

    medications that mimic dopamine by stimulating its brain receptors

    Dopamine agonists, also known as dopamine receptor agonists or DA agonists, are medications that mimic the action of dopamine by stimulating dopamine receptors in the brain. They are commonly used to treat conditions like Parkinson's disease and restless legs syndrome by compensating for low dopamine levels, thereby improving symptoms such as motor control and mood.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 635 results

    Community Join

    5 / 41 results

      community What would hair loss treatment be like in the 2030s?

      in Treatment  5 upvotes 4 months ago
      The conversation discusses future hair loss treatments, with mentions of dutasteride potentially gaining FDA approval and increased popularity. Skepticism remains about significant advancements due to limited funding and reliance on cosmetic companies.

      community Nandrolone Replacement Therapy

      in Treatment  41 upvotes 1 year ago
      A user discusses starting nandrolone replacement therapy to stop hair loss and improve hair health, noting its benefits over finasteride. They report halted hair loss, improved skin, increased muscle, and a calm mood after three weeks.

      community HMI 115 Phase 2 - Leaked pics from Discord

      in Research/Science  361 upvotes 6 months ago
      The conversation discusses HMI 115, a new hair loss treatment with promising results, showing a significant increase in hair density after two months. Some users are skeptical, while others are hopeful for its release and potential affordability.

      community hmi115 is coming. Prepare yourselves for what's coming

      in Technology  106 upvotes 1 year ago
      The conversation discusses HMI-115, a potential cure for hair loss. Users share mixed opinions, with some expressing skepticism and others sharing anecdotal evidence of its effectiveness, including photos of significant hair regrowth from a trial participant.